Sign Up
QUESTIONSPre-Approval Statements and Representations by Pharmaceutical Manufacturers - Webinar By ComplianceO (FDA GXP Compliance -)
Venue: Online Event
Location: Palo Alto, California, United States
| Event Date/Time: May 24, 2012 | End Date/Time: May 24, 2012 |
Report as SpamDescription
Why Should You Attend:-
Off-label uses cannot be legally promoted. Promoting off-label uses may be viewed by FDA as actionable under the False Claims Act. Criminal and civil liabilities can be substantial for manufacturers. One recent settlement agreement with FDA went into the hundreds of millions of dollars.
Areas Covered in the Seminar:-
- How social media interactions can be handled.
- Contours of First Amendment freedom of speech protections.
- Promotion vs dissemination of information – types of communications.
- Solicited vs unsolicited information requests.
- Legally permitted limits on Commercial speech.
- Examples of recent cases dealing with communications about off-label uses of pharmaceuticals.
Off-label uses cannot be legally promoted. Promoting off-label uses may be viewed by FDA as actionable under the False Claims Act. Criminal and civil liabilities can be substantial for manufacturers. One recent settlement agreement with FDA went into the hundreds of millions of dollars.
Areas Covered in the Seminar:-
- How social media interactions can be handled.
- Contours of First Amendment freedom of speech protections.
- Promotion vs dissemination of information – types of communications.
- Solicited vs unsolicited information requests.
- Legally permitted limits on Commercial speech.
- Examples of recent cases dealing with communications about off-label uses of pharmaceuticals.
